EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 15 filers reported holding EYEGATE PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,000 | -25.0% | 12,355 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | -33.3% | 12,355 | 0.0% | 0.00% | – |
| Q4 2018 | $6,000 | +50.0% | 12,355 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | -42.9% | 12,355 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | +40.0% | 12,355 | -0.0% | 0.00% | – |
| Q1 2018 | $5,000 | – | 12,356 | +1235500.0% | 0.00% | – |
| Q4 2017 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,192,000 | $453,000 | 0.04% |
| IFP Advisors, Inc | 23,800 | $25,000 | 0.00% |
| Holistic Financial Partners | 1,900 | $1,000 | 0.00% |
| Vantage Investment Advisors, LLC | 6,500 | $2,000 | 0.00% |
| WEDBUSH SECURITIES INC | 20,000 | $8,000 | 0.00% |
| US BANCORP \DE\ | 40,650 | $15,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 100 | $0 | 0.00% |
| NORTHERN TRUST CORP | 14,553 | $6,000 | 0.00% |
| CREDIT SUISSE AG/ | 26,500 | $10,000 | 0.00% |
| MORGAN STANLEY | 7,721 | $3,000 | 0.00% |